Stryker price target lowered to $405 from $410 at Evercore ISI

Evercore ISI lowered the firm’s price target on Stryker (SYK) to $405 from $410 and keeps an Outperform rating on the shares. Stryker’s Q3 performance was solid with a 9.5% organic growth, slightly topping Wall Street estimates, mainly driven by Orthopedics’ strong showing, the analyst tells investors in a research note. The firm noted that MedSurg and NeuroTech held steady, though Endoscopy and Medical lagged a bit behind expectations.